glp-1 market size 2024 Industry Trends and Global Forecasts Global GLP-1 Receptor Agonist Market

Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy for weight management, Ozempic for type 2 diabetes) and tirzepatide (a dual GIP/GLP-1 receptor agonist marketed as Zepbound for weight management and Mounjaro for type 2 diabetes), have become increasingly prescribed medications

Losing weight with a GLP-1 medication is a powerful tool, but theres more involved

The website publishes 4 clinical studies to support the effects of Lemme GLP-1 Daily

doi:10.2337/db15-1255 17

In Australia, Ozempic is only approved and subsidised for patients with diabetes, but doctors can use their own discretion to prescribe it for patients wanting to lose weight at full price

32 A meta-analysis of over 76 clinical trials that investigated the efficacy of 15 different types of GLP-1RAs revealed that all 15 of the drugs were highly effective at treating T2D